Home › Amyloidosis
Pag-aaral pangklinika para sa Amyloidosis na nagre-recruit sa U.S.
29 pag-aaral para sa Amyloidosis ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Boston, MA11 pag-aaral
- Rochester, MN10 pag-aaral
- New York City, NY10 pag-aaral
- Dallas, TX9 pag-aaral
- Philadelphia, PA7 pag-aaral
- St. Louis, MO6 pag-aaral
- Baltimore, MD6 pag-aaral
- Portland, OR6 pag-aaral
- Houston, TX6 pag-aaral
- Durham, NC6 pag-aaral
- Chicago, IL5 pag-aaral
- San Diego, CA5 pag-aaral
- Cleveland, OH5 pag-aaral
- Washington, DC5 pag-aaral
- Nashville, TN5 pag-aaral
- Charlotte, NC4 pag-aaral
- Detroit, MI4 pag-aaral
- Richmond, VA4 pag-aaral
- Seattle, WA4 pag-aaral
- Los Angeles, CA4 pag-aaral
- Jacksonville, FL4 pag-aaral
- San Francisco, CA4 pag-aaral
- Miami, FL3 pag-aaral
- Arlington, VA3 pag-aaral
- Mountain View, CA3 pag-aaral
- Austin, TX3 pag-aaral
- Kansas City, KS3 pag-aaral
- Columbus, OH3 pag-aaral
- Charleston, SC3 pag-aaral
- Indianapolis, IN3 pag-aaral
- Atlanta, GA3 pag-aaral
- Aurora, CO3 pag-aaral
- Salt Lake City, UT3 pag-aaral
- Edison, NJ3 pag-aaral
- New Haven, CT3 pag-aaral
- Kansas City, MO3 pag-aaral
Ayos sa estado
- Arizona3 pag-aaral
- California8 pag-aaral
- Colorado5 pag-aaral
- Connecticut4 pag-aaral
- District of Columbia4 pag-aaral
- Florida8 pag-aaral
- Georgia3 pag-aaral
- Illinois5 pag-aaral
- Indiana3 pag-aaral
- Kansas3 pag-aaral
- Maryland7 pag-aaral
- Massachusetts11 pag-aaral
- Michigan5 pag-aaral
- Minnesota10 pag-aaral
- Missouri7 pag-aaral
- New Jersey3 pag-aaral
- New York10 pag-aaral
- North Carolina10 pag-aaral
- Ohio6 pag-aaral
- Oregon6 pag-aaral
- Pennsylvania7 pag-aaral
- South Carolina4 pag-aaral
- Tennessee7 pag-aaral
- Texas11 pag-aaral
- Utah3 pag-aaral
- Virginia4 pag-aaral
- Washington4 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05652335Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06465810TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Nagre-recruitPhase 3
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07052903TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
Nagre-recruitPhase 3
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07223203DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07358078Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Kababaihan · Na-update Set 8, 2026 · NCT05040373ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Set 8, 2026 · NCT04561518Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
Nagre-recruit
Edad 65 pataas · Lahat ng kasarian · Na-update Set 1, 2026 · NCT05577819Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers
Nagre-recruitObservasyonal na pag-aaral
Edad 30 hanggang 80 · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT05489549Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT05145816Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT06563895The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT07285044Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis
Nagre-recruitPhase 4
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT07695701A Phase 1 Study of 99mTc-p5+14 in Healthy Volunteers and Patients With AL or ATTR Systemic Amyloidosis
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 24, 2026 · NCT05951816[64Cu]FBP8 PET for Early Detection of Intracardiac Thrombus in Amyloid Cardiomyopathy
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 21, 2026 · NCT07560306A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 17, 2026 · NCT07224672A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT07081646Dietary Reporting In The Amyloidoses
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 26, 2026 · NCT05738005Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid Load
Nagre-recruitPhase 1
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update May 19, 2026 · NCT06974877A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update May 13, 2026 · NCT06158854Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis
Nagre-recruitPhase 2
Edad 40 hanggang 90 · Lahat ng kasarian · Na-update Abr 13, 2026 · NCT05758493MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Nagre-recruitPhase 3
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Mar 27, 2026 · NCT06128629Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients With ATTR-CM: Longitudinal Biomarker Study
Nagre-recruitObservasyonal na pag-aaral
Edad 30 hanggang 80 · Lahat ng kasarian · Na-update Ene 7, 2026 · NCT07196839Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 31, 2025 · NCT04991103A Study Of Myocardial Stiffness In Amyloidosis With Magnetic Resonance Elastography
Nagre-recruitObservasyonal na pag-aaral
Edad 20 pataas · Lahat ng kasarian · Na-update Dis 26, 2025 · NCT07216469Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.